Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Synpromics named among the top 50 fastest growing technology companies in the UK

Synpromics, the leader in gene control, is delighted to announce that it has been ranked 12th in the Deloitte ‘UK Technology Fast 50’ at the annual awards ceremony in London.

Read the rest of entry »

Immunocore and Genentech Expand Partnership to Develop Cancer Immunotherapy MEDICAL

Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore’s immunotherapy for treating solid tumors.

Read the rest of entry »

Leading recruitment agency assembles new Operations Team to spearhead its ‘next generation flexible work model’

SRG, the leading science, clinical and engineering recruitment agency, is today announcing a new operational leadership team for Synergy, its flexible science insourcing service dubbed the ‘next generation flexible work model’. 

Read the rest of entry »

Induced Pluripotent Stem Cells for Regenerative Research

AMSBIO announces that induced pluripotent stem (iPS) cell expert - Dr Masato Nakagawa from the Nobel Prize winning Yamanaka Lab** at the Centre for iPS Cell Research and Application, Kyoto University, Japan will give 3 talks in the UK on the 10th and 11th December 2018.

Read the rest of entry »

AMSBIO Expand Range of FFPE Cancer Cell Line Controls

AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications.
 

Read the rest of entry »

Evox Therapeutics has secured £655,000 in funding from Duchenne UK

Evox Therapeutics has secured £655,000 in funding from Duchenne UK, to support exploration of its exosome-based therapeutic platform for the condition.Duchenne is a highly debilitating, progressive, muscle-wasting disorder caused by the lack of functional dystrophin protein, for which there is currently no cure.

Read the rest of entry »

Abingdon Health launches App that transforms a Smartphone into a rapid analytical tool

13 November 2018: BioHub Birmingham® tenant Abingdon Health has launched an intuitive software application called AppDx. AppDx enables a Smartphone to ‘read’ lateral flow test lines, using the inbuilt camera, which translates the image into numerical data.  

Read the rest of entry »

Diamond Win Two Categories in the 2018 TOPRA Awards

Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs consulting group, providing expert support and advice to pharmaceutical and biotechnology companies, has received both the Futures and Support Award at The Organisation for Professionals in Regulatory Affairs (TOPRA) Awards.

Read the rest of entry »

Absolute Antibody Opens New Facility to Support Continued Growth of its Recombinant Antibody Technology

Absolute Antibody specialises in recombinant antibody products and services. All of our manufacturing takes place in the UK, but over 70% of our revenue comes from international exports. This expansion will allow us to meet growing global demand for recombinant antibody technology across the pharmaceutical, diagnostics, and academic sectors.

Read the rest of entry »

Wickham Laboratories to Exhibit at Pharmig 2018

Wickham Laboratories will be exhibiting at Pharmig’s 26th annual conference held on the 28th & 29th November at the Belfry Hotel, Nottingham.

This year’s event will bring together an array of industry experts and regulators to discuss the latest research and findings within the pharmaceutical microbiology industry.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.